DBD

Diebold Nixdorf, Incorporated

Price

$63.77

return (12m)

9.55%

p/e

19.93

p/bv

2.27

DIVIDEND YIELD

0.00%

DBD price

Diebold Nixdorf, Incorporated

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment DBD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-7.14%

3 months

-23.62%

1 year

9.55%

2 years

45.03%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals DBD

Valuation

P/E

19.93

Sector 7.51

Industry 7.51

P/BV

2.27

Sector 1.74

Industry 1.74

P/Revenue (PSR)

0.57

Sector 1.69

Industry 1.69

EV/EBITDA

31.55

Sector -845.43

Industry -845.43

EV/EBIT

47.64

Sector -3,320.87

Industry -3,320.87

P/EBITDA

5.86

Sector -11.07

Industry -11.07

P/EBIT

8.74

Sector -9.99

Industry -9.99

P/Total Assets

0.59

Sector 0.83

Industry 0.83

P/Net Current Assets

-2.11

Sector -1.86

Industry -1.86

P/Working Capital

6.14

Sector -4,700.45

Industry -4,700.45

EPS

3.23

Sector 0.72

Industry 0.72

BVPS

28.39

Sector 9.78

Industry 9.78

Efficiency

Gross Margin

25.25%

Sector 35.82%

Industry 35.82%

EBITDA Margin

9.80%

Sector -200.09%

Industry -200.09%

EBIT Margin

6.49%

Sector -130.42%

Industry -130.42%

Operating Margin

6.36%

Sector 4.48%

Industry 4.48%

Net Profit Margins

2.87%

Sector 2.53%

Industry 2.53%

Asset Turnover

0.25

Sector 0.11

Industry 0.11

Profitability

ROE

11.39%

Sector 2.55%

Industry 2.55%

ROA

2.98%

Sector -0.60%

Industry -0.60%

ROIC

4.92%

Sector -120.08%

Industry -120.08%

Dividends

Dividend yield

0.00%

Sector 0.53%

Industry 0.53%

Payout

0.00%

Sector 9.87%

Industry 9.87%

Debt

Current Ratio

1.27

Sector 1.47

Industry 1.47

Net Debt / EBITDA

7.24

Sector -20.47

Industry -20.47

Net Debt / EBIT

10.94

Sector -164,248,318.64

Industry -164,248,318.64

Net Debt / Equity

0.68

Sector -0.77

Industry -0.77

Gross Debt / Equity

0.97

Sector 0.20

Industry 0.20

Equity/Assets

0.26

Sector 0.43

Industry 0.43

Liabilities/Assets

0.74

Sector 0.53

Industry 0.53

Growth

5Y Revenue CAGR

-0.17%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals DBD

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Diebold Nixdorf, Incorporated ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$63.77

Fair Value

$45.42

Upside

-28.77%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

DBD - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Diebold Nixdorf, Incorporated

Diebold Nixdorf, Incorporated

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

2023

Time since IPO - 3 years

20.000

Employees

Diebold Nixdorf, Incorporated (United States) is listed on the Nasdaq and has a market capitalization of $2.22 billion, with shareholders equity totaling $976.50 million.

The company employs approximately 20.000 people and operates in the Others sector, within the Others industry.

Over the past 12 months, Diebold Nixdorf, Incorporated reported $3.87 billion in revenue, generating net income of $111.20 million.

Key financial metrics include a P/E ratio of 19.93, a price-to-book (P/B) ratio of 2.27, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker DBD.

Market cap

$2.22 billion

Net worth

$976.50 million

$976,500,000.00

Assets

$3.74 billion

$3,736,600,000.00

Total Shares Outstanding

34.40 million

34,400,000

Average Daily Trading Volume

$274.39 Thousand

$274,392.76

Sector

Others

Industry

Others

DBD

DBD revenue and profits

Financial Results DBD

DRAG THE FRAME TO SEE MORE DATA

DBD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$371.90 5,99% (12M)

P/E

23.51

2.46%

ROE

13.51%

P/BV

3.18

SHEL - Shell PLC ADR

$96.23 36,34% (12M)

P/E

10.30

3.16%

ROE

14.29%

P/BV

1.47

STLA - Stellantis NV

$4.40 --58,99% (12M)

P/E

-0.50

0.00%

ROE

-35.93%

P/BV

0.18

COR - Cencora Inc.

$309.05 2,85% (12M)

P/E

22.61

0.78%

ROE

81.03%

P/BV

18.32

ALIZY - Allianz SE ADR

$46.83 --19,17% (12M)

P/E

12.88

2.91%

ROE

17.89%

P/BV

2.30

TTE - TotalEnergies SE ADR

$84.46 50,46% (12M)

P/E

6.86

4.78%

ROE

21.42%

P/BV

1.47

NSRGY - Nestle SA ADR

$90.24 1,04% (12M)

P/E

10.81

4.45%

ROE

58.05%

P/BV

6.27

ELV - Elevance Health Inc

$386.43 12,43% (12M)

P/E

19.87

1.71%

ROE

9.84%

P/BV

1.96